Diagana, Thierry Tidiane, Yeung, Bryan King Sing, Manjunatha, Ujjini Havaldar, Shi, Pei-Yong, Bodenreider, Christophe and Jones, Catherine (2014) Ten years of drug discovery for the developing world at the Novartis Institute for Tropical Diseases. Nature Reviews Drug Discovery, 14 (6). pp. 442-444. ISSN 1474-1784

Abstract

In 2013, the Novartis Institute for Tropical Diseases (NITD) celebrated ten years of drug discovery research targeting neglected infectious diseases. Established as a public-private partnership between Novartis and the Singapore Economic Development Board, NITD was founded with the expectation that applying drug discovery expertise and cutting-edge technologies could confront the challenges of producing medicines for the developing world. In the past decade, NITD has identified two new malaria drugs now in early clinical trials, several promising leads for tuberculosis, and tool compounds for dengue fever. Key to these successes has been furthering the understanding of disease biology, applying advanced drug discovery technologies, and partnering with academic experts throughout the world.

Item Type:	Article
Date Deposited:	29 Apr 2016 23:45
Last Modified:	29 Apr 2016 23:45
URI:	https://oak.novartis.com/id/eprint/21681